naftopidil and Lung Neoplasms

naftopidil has been researched along with Lung Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gotoh, A; Kanno, T; Mikami, K; Nagaya, H; Nakano, T; Nishizaki, T; Tsuchiya, A	1

Other Studies

1 other study(ies) available for naftopidil and Lung Neoplasms

Article	Year
Naftopidil is useful for the treatment of malignant pleural mesothelioma. Pharmacology, 2014, Volume: 94, Issue:3-4 Topics: Adrenergic alpha-Antagonists; Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Caspase 8; Caspase 9; Cell Line, Tumor; Fas Ligand Protein; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Mice, Nude; Naphthalenes; Piperazines; RNA, Messenger; Tumor Burden; Tumor Necrosis Factor-alpha	2014

Article

Year

Naftopidil is useful for the treatment of malignant pleural mesothelioma.

Pharmacology, 2014, Volume: 94, Issue:3-4

Topics: Adrenergic alpha-Antagonists; Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Caspase 8; Caspase 9; Cell Line, Tumor; Fas Ligand Protein; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Mice, Nude; Naphthalenes; Piperazines; RNA, Messenger; Tumor Burden; Tumor Necrosis Factor-alpha

2014